SCHEMBL8315566

SCHEMBL8315566

CCOC(=O)OC1C(C)C(C)C(C)N1C(=O)Cc1ccc(C)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NLRP3 Q96P20 1/20 0.33
P2RX7 Q99572 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31
NR3C2 P08235 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
SRC P12931 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
ALOX12 P18054 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8316836 0.85 NLRP3 (0.33) SMN1; SMN2CYP3A4NLRP3MEN1KMT2A
SCHEMBL8318325 0.82 KMT2A (0.39) SMN1; SMN2CYP3A4CYP2C9P2RX7KMT2A
SCHEMBL8316807 0.82 SMN1; SMN2 (0.37) SMN1; SMN2CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL8875491 0.81 SMN1; SMN2 (0.40) SMN1; SMN2CYP1A2CYP2C9CYP2C19P2RX7
SCHEMBL8313464 0.80 NLRP3 (0.33) SMN1; SMN2CYP1A2CYP2C9CYP2C19NLRP3
SCHEMBL8317735 0.80 SMN1; SMN2 (0.37) SMN1; SMN2CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL8312314 0.79 SMN1; SMN2 (0.38) SMN1; SMN2CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL8314698 0.78 SMN1; SMN2 (0.35) SMN1; SMN2CYP3A4P2RX7L3MBTL1MEN1
SCHEMBL8314030 0.77 SMN1; SMN2 (0.36) SMN1; SMN2CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL8312553 0.77 ALDH1A1 (0.40) SMN1; SMN2MEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0501129-B1 Substituted bicyclic 3-arylpyrrolidin-2,4-dion derivatives BAYER AG (DE) 1999-07-14 EP disclosed
EP-0501129-A1 Substituted bicyclic 3-arylpyrrolidin-2,4-dion derivatives BAYER AG (DE) 1992-09-02 EP disclosed